Friday, December 03, 2021 10:05:36 AM
Data issued today from South Africa show, in contrast to the Beta and #Delta, the #Omicron variant shows substantial evidence for evasion of immunity from prior infection. Highlights the critical need for effective therapies that are #variantagnostic. https://t.co/SHQiF1noTg
— Humanigen, Inc. (@humanigen) December 3, 2021
Data issued today from South Africa show, in contrast to the Beta and #Delta, the #Omicron variant shows substantial evidence for evasion of immunity from prior infection. Highlights the critical need for effective therapies that are #variantagnostic.
https://www.medrxiv.org/content/10.1101/2021.11.11.21266068v2.full.pdf
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM